Evidence report on: Treatment of depression - Newer pharmacotherapies

Psychopharmacology Bulletin

Volumn 34, Issue 4, 1998, Pages 409-795

  Mulrow, C D ^a   Williams J W , Jr ^a   Trivedi, M ^a   Chiquette, E ^a   Aguilar, C ^a   Cornell, J E ^a   Badgett, R ^a   Hitchcock Noel, P ^a   Lawrence, V ^a   Lee, S ^a   Luther, M ^a   Ramirez, G ^a   Richardson, W S ^a   Stamm, K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; AURONIX; BROFAROMINE; CITALOPRAM; FEMOXETINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; GEPIRONE; INDALPINE; IPSAPIRONE; LITOXETINE; MEDIFOXAMINE; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PAROXETINE; REBOXETINE; RITANSERIN; SERALGAN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TANDOSPIRONE; TOLOXATONE; TREWILOR; TRICYCLIC ANTIDEPRESSANT AGENT; UMORIL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE; VILOXAZINE; VITALOPRAM; ANTIDEPRESSANT AGENT;

DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG RESPONSE; DRUG SCREENING; DYSTHYMIA; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERICUM PERFORATUM; PRIORITY JOURNAL; REVIEW; VISUAL IMPAIRMENT; XEROSTOMIA; ADULT; CHILD; EVIDENCE BASED MEDICINE; PSYCHOLOGICAL ASPECT;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHILD; DEPRESSIVE DISORDER; EVIDENCE-BASED MEDICINE; HUMANS;

EID: 0032235659     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (731)